Publications by authors named "Katherine Naff"

Article Synopsis
  • Breast cancer patients resistant to neoadjuvant chemotherapy (NeoCT) have a poor prognosis, creating a need for effective in vivo models to test new treatments.
  • The study established 13 patient-derived breast cancer xenografts (BCXs) from 48 tumors, showing higher engraftment rates in triple-negative breast cancer (TNBC) and in patients who had poor responses to NeoCT.
  • Results indicate that BCXs maintain genomic profiles and are linked to worse outcomes, suggesting they can serve as valuable models for researching personalized treatments in aggressive breast cancers.
View Article and Find Full Text PDF

TP53 is commonly altered in human cancer, and Tp53 reactivation suppresses tumours in vivo in mice (TP53 and Tp53 are also known as p53). This strategy has proven difficult to implement therapeutically, and here we examine an alternative strategy by manipulating the p53 family members, Tp63 and Tp73 (also known as p63 and p73, respectively). The acidic transactivation-domain-bearing (TA) isoforms of p63 and p73 structurally and functionally resemble p53, whereas the ΔN isoforms (lacking the acidic transactivation domain) of p63 and p73 are frequently overexpressed in cancer and act primarily in a dominant-negative fashion against p53, TAp63 and TAp73 to inhibit their tumour-suppressive functions.

View Article and Find Full Text PDF

The mammalian target of rapamycin (mTOR) is a central controller of cell growth and is currently being investigated as a potential target in breast cancer therapy. The essential amino acid leucine has been proposed to regulate mTOR signaling. The objective of this study was to determine whether leucine restriction would inhibit mTOR signaling in breast cancer cells.

View Article and Find Full Text PDF

Efforts to develop adenovirus vectors suitable for genetic interventions in humans have identified three major limitations of the most frequently used vector prototype, human adenovirus serotype 5 (Ad5). These limitations--widespread preexisting anti-Ad5 immunity in humans, the high rate of transduction of normal nontarget tissues, and the lack of target-specific gene delivery--justify the exploration of other Ad serotypes as vector prototypes. In this paper, we describe the development of an alternative vector platform using simian Ad serotype 24 (sAd24).

View Article and Find Full Text PDF

Objective: Connective tissue growth factor (CTGF) is a cysteine-rich secreted matricellular protein involved in wound healing and tissue repair. Enhanced and prolonged expression of CTGF has been associated with tissue fibrosis in humans. However, questions remain as to whether CTGF expression alone is sufficient to drive fibrosis.

View Article and Find Full Text PDF

Daily vacuuming of floors and flat-shelf racks is a standard procedure in our rodent housing rooms. To determine whether the noise produced by this activity is a potential stressor to animals used for transgenic and knockout mouse production, we measured the sound levels in our genetically engineered mouse facility under ambient conditions and at the in-cage and room levels during vacuuming. Spectral analysis showed that vacuuming produces a multitonal, low-frequency noise that is not attenuated by microisolation caging with bedding material.

View Article and Find Full Text PDF